JP Morgan Chase
AEON icon

JP Morgan Chase’s AEON Biopharma AEON Stock Holding History

JP Morgan Chase’s Portfolio AEON Stock Details AEON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1
Closed -$29 – 7287
2024
Q4 		$29 Hold
1
– – ﹤0.01% 7217
2024
Q3 		$61 Buy
+1
New +$88 ﹤0.01% 7078
2024
Q2 		– Sell
-396
Closed -$94.4K – 7097
2024
Q1 		$331K Buy
396
+300
+313% +$217K ﹤0.01% 5055
2023
Q4 		$49.6K Buy
+96
New +$38.6K ﹤0.01% 6004
2022
Q2 		– Sell
-1,432
Closed -$1.01M – 6427
2022
Q1 		$1.01M Sell
1,432
-2,361
-62% -$1.66M ﹤0.01% 4251
2021
Q4 		$2.66M Buy
+3,793
New +$2.67M ﹤0.01% 3620

Other funds holding AEON

DIG
Dauntless Investment Group Etna, New Hampshire $151M AUM 76.14% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
DCM
Dupont Capital Management Wilmington, Delaware $2.18M AUM 50.81% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

JP Morgan Chase's AEON Position: Q1 2025 in Review

JP Morgan Chase sold out of AEON Biopharma (AEON) in Q1 2025, closing a stake of 1 share — an estimated $29 sold.

JP Morgan Chase first reported a position in AEON in Q4 2021 and held it in 6 quarters. The position peaked at $2.66M in Q4 2021. 16 funds tracked by Wall St. Rank hold AEON as of Q1 2025.

  • JP Morgan Chase reported no remaining AEON Biopharma position as of Q1 2025 after selling out during the quarter.
  • JP Morgan Chase sold 1 AEON Biopharma share in Q1 2025, an estimated $29.
  • JP Morgan Chase first reported a position in AEON Biopharma in Q4 2021 and held it in 6 quarters.
  • JP Morgan Chase's AEON Biopharma position peaked at $2.66M in Q4 2021.
  • 16 funds tracked by Wall St. Rank held AEON Biopharma as of Q1 2025.

Based on JP Morgan Chase's 13F filing for Q1 2025, filed 12 May 2025.